rejection: search

Geron Issues Statement Regarding European Patent Office Decision in WARF Patent Appeal

MENLO PARK, Calif.--(Business Wire)-- Geron Corporation (Nasdaq: GERN) announced that the Enlarged Board of Appeals of the European Patent Office (EPO) has issued a decision in case G0002/06, which was an appeal by the Wisconsin Alumni Research Foundation (WARF) against the rejection of claims in WARF’s European Patent Application No. 96903521.1. The claims of the application pertain to the first isolation of human embryonic stem cells (hESCs) by Dr. James Thomson at the University of Wisconsin. The decision upholds the rejection of WARF’s claims as being impermissible under a rule of the European Patent Convention that prohibits the patenting of inventions which concern “the uses of human embryos for industrial or commercial purposes.

Fed. Circ. Upholds Rejection Of Cancer Patent Claim

Law360, New York (October 31, 2008) -- A patent application describing a method for treating a rare form of cancer was appropriately rejected for lacking adequate written description because the patent's specification described only a single antibody, while the contested patent claim involved a much larger grouping of antibodies, the U.S. Court of Appeals for the Federal Circuit has ruled.

IPAB to look into patent rejection of Glivec this month

Mumbai, Nov. 3 The review of the rejected patent on Novartis’ cancer-drug Glivec is set to be heard by the Intellectual Property Appellate Board (IPAB) on a ‘day to day’ basis, starting November 17. Novartis’ patent application on Glivec had been rejected by the Indian Patent Office in January 2006.

Patent ruling: Good or bad for tech innovation?

A rejection of a patent application by a U.S. appeals court today is expected to send shockwaves through some industries, notably the software industry, as it will likely put an end to the patenting of “business methods” considered to be more entrepreneurial than innovative. Meanwhile, some say the ruling is a victory for innovation and exactly what’s been needed to bring an end to patent hoarding practices and frivolous patent lawsuits.

Patents panel wants Novartis documents on efficacy claims

The Swiss drug maker had appealed the rejection by the Chennai patent office of its patent application for blood cancer drug Glivec

Opera on iPhone shot down? Never happened

PCWorld reports that the uproar surrounding Apple's purported AppStore rejection of Opera Mini was all for naught. In fact, the alternate mobile browser hasn't been submitted to the mothership for review.

European Patent Office Nixes WARF Application, Again

(BioWorld Today Via Acquire Media NewsEdge) LONDON - There was a second and final rejection of the University of Wisconsin's infamous WARF human embryonic stem cell patent from the European Patent Organization (EPO) last week.

Sarah Boseley on the stem cell transplant of an organ

Sarah Boseley reports on the transplant of a human organ using stem cells to stop rejection, involving Bristol University

Opera Mini Not Rejected From IPhone (Yet)

danaris writes in to inform us that John Gruber has done some digging on the reported rejection from the App Store of Opera Mini, and has written up his findings. Some choice excerpts: "My understanding, based on information from informed sources who do not wish to be identified because they were not authorized by their employers, is that Opera has developed an iPhone version of Opera Mini — but they haven't even submitted it to Apple, let alone had it be rejected. ... If what they've done for the iPhone is [to get] a Java ME runtime running on the iPhone — it's clearly outside the bounds of the iPhone SDK Agreement. ... What Opera would need to do to have a version of Opera Mini they could submit to the App Store would be to port the entire client software to the C and Objective-C APIs officially supported on the iPhone.

What The Blogs Are Saying About Jerry Yang Out As Yahoo CEO

will step down after the company finds a replacement, following a tumultuous and short tenure that included the company's rejection of an offer by

Patent Ruling Dodges Constitutionality Question

Law360, New York (November 04, 2008) -- The U.S. Court of Appeals for the Federal Circuit on Monday upheld the rejection of a patent for a health supplement juice despite the juice maker’s contention that two judges who ruled on the patent were appointed unconstitutionally.

Stem-Cell Trachea Technique 'Has Great Promise'

Medical researchers reported growing tissue for a new windpipe from a patient's own stem cells, a procedure that eliminates the need for anti-rejection drugs. The transplant study was published online in The Lancet.

Geron Corporation comments on decision concerning WARF patent appeal in Europe

Geron Corporation (Nasdaq: GERN), a biopharmaceutical company, reported on 27 November that as regards to the appeal by Wisconsin Alumni Research Foundation (WARF) against the rejection of claims in WARF's European Patent Application No. 96903521.1, a decision has been issued by the Enlarged Board of Appeals of the European Patent Office (EPO).

Letter to Fall Recruits: Clean Up Your (Cyber)Space

Right now at law firms across the country, recruiters are making tough choices and considering tough questions. How many offers to extend? When to send out the rejection letters? When to take candidates off the hold list?

Geron Issues Statement Regarding European Patent Office Decision in WARF Patent Appeal

announced that the Enlarged Board of Appeals of the European Patent Office (EPO) has issued a decision in case G0002/06, which was an appeal by the Wisconsin Alumni Research Foundation (WARF) against the rejection of claims in WARF's European Patent Application No. 96903521.1. The claims of the application pertain to the first isolation of human embryonic stem cells (hESCs) by Dr. James Thomson at the University of Wisconsin.

Europeans announce pioneering stem cell surgery

PARIS: Physicians at four European universities have completed what they say is the first successful transplant of a human windpipe, using a patient's own stem cells to fashion an organ and prevent its rejection by her immune system, according to an article in the British medical journal The Lancet. One of the physicians said the surgery could herald a "new age in surgical care."

The Greatest iPhone App You Can't Buy: "Aqua Obama"

(Sadly) rejected from Apple's (AAPL) iPhone app store: "Aqua Obama," from the maker of "Aqua Hoops," "Aqua Punt," and "Aqua Pitch"... NYC-based programmer E.J. Mablekos. Not much explanation for the rejection in the video below except, "I don't really feel like reading the NDA."

Geron Issues Statement Regarding European Patent Office Decision

Geron Corporation GERN announced that the Enlarged Board of Appeals of the European Patent Office (EPO) has issued a decision in case G0002/06, which was an appeal by the Wisconsin Alumni Research Foundation (WARF) against the rejection of claims in WARF’s European Patent Application No. 96903521.1. The claims of the application pertain to the first isolation of human embryonic stem cells (hESCs) by Dr. James Thomson at the University of Wisconsin.

Bloggers who take it one post at a time

There's SlowSex (apparently; first I'd heard of it), SlowCities, and SlowFood. Now, the New York Times reports, there is also Slow Blogging, which Todd Sieling, a Canadian technology consultant, defined in a manifesto as "a rejection of immediacy ... an affirmation that not all things worth reading are written quickly". This is an idea that appeals to me. Call me old-fashioned, but I believe in the mot juste. Words, as a rule, are better weighed before use, and too many blog posts - and particularly blog comments - are, well, not.

Geron Issues Statement Regarding European Patent Office Decision in WARF Patent Appeal

Geron Corporation (Nasdaq: GERN) announced that the Enlarged Board of Appeals of the European Patent Office (EPO) has issued a decision in case G0002/06, which was an appeal by the Wisconsin Alumni Research Foundation (WARF) against the rejection of claims in WARF’s European Patent Application No. 96903521.1. The claims of the application pertain to the first isolation of human embryonic stem cells (hESCs) by Dr. James Thomson at the University of Wisconsin.

Geron Issues Statement Regarding European Patent Office Decision in WARF Patent Appeal

Geron Corporation (Nasdaq: GERN) announced that the Enlarged Board of Appeals of the European Patent Office (EPO) has issued a decision in case G0002/06, which was an appeal by the Wisconsin Alumni Research Foundation (WARF) against the rejection of claims in WARF’s European Patent Application No. 96903521.1. The claims of the application pertain to the first isolation of human embryonic stem cells (hESCs) by Dr. James Thomson at the University of Wisconsin.

Geron Issues Statement Regarding EPO Decision in WARF Patent Appeal

MENLO PARK, CA - Geron Corporation announced that the Enlarged Board of Appeals of the European Patent Office (EPO) has issued a decision in case G0002/06, which was an appeal by the Wisconsin Alumni Research Foundation (WARF) against the rejection of claims in WARF's European Patent Application No. 96903521.1.

Geron Issues Statement Regarding European Patent Office Decision in WARF Patent Appeal

MENLO PARK, Calif. - Geron Corporation (Nasdaq: GERN) announced that the Enlarged Board of Appeals of the European Patent Office (EPO) has issued a decision in case G0002/06, which was an appeal by the Wisconsin Alumni Research Foundation (WARF) against the rejection of claims in WARF’

Revealed: young Freud's clash with art establishment

The spidery, ink-stained scrawl, littered with cross-outs and spelling mistakes, could be that of a primary school pupil. Few would guess it was the handwriting of Britain's greatest living painter as he expressed his dismay at the art establishment's rejection of his work.

Urine Protein Test Detects Kidney Dysfunction In Transplant Patients

A noninvasive test that analyzes proteins in the urine can correctly identify patients whose transplanted kidneys are failing, according to a new study. The results might allow physicians to more accurately monitor transplant patients and to fine-tune the immunosuppressive therapies prescribed to prevent kidney rejection.

Search took 0.02 seconds.